(Q35802781)

10 August 2017

The effects of age and gender on the pharmacokinetics of irbesartan (English)

1 reference

10 August 2017

1 reference

N N Vachharajani

1

1 reference

10 August 2017

W C Shyu

series ordinal

2

1 reference

10 August 2017

R A Smith

series ordinal

3

1 reference

10 August 2017

D S Greene

series ordinal

4

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 December 1998

1 reference

British Journal of Clinical Pharmacology

10 August 2017

1 reference

10 August 2017

46

1 reference

10 August 2017

6

1 reference

10 August 2017

611-613

1 reference

Angiotensin II receptors and angiotensin II receptor antagonists.

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873803

Angiotensin II receptor blockade: an innovative approach to cardiovascular pharmacotherapy

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873803

Prevalence of Hypertension in the US Adult Population : Results From the Third National Health and Nutrition Examination Survey, 1988-1991

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873803

Angiotensin receptor antagonists: focus on losartan

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873803

The application of statistical moment theory to the evaluation of in vivo dissolution time and absorption time.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873803

The pharmacokinetics of irbesartan in renal failure and maintenance hemodialysis

25 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1046%2FJ.1365-2125.1998.00837.X

Oral bioavailability and disposition characteristics of irbesartan, an angiotensin antagonist, in healthy volunteers

21 January 2018

1 reference

12 December 2020

Pharmacological characterization of SR 47436, a new nonpeptide AT1 subtype angiotensin II receptor antagonist

1 reference

12 December 2020

1 reference

12 December 2020

High-performance liquid chromatographic assay for the quantitation of irbesartan (SR 47436/BMS-186295) in human plasma and urine

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of irbesartan in healthy subjects

1 reference

12 December 2020

Hemodynamic and biochemical effects of the AT1 receptor antagonist irbesartan in hypertension

1 reference

12 December 2020

10.1046/J.1365-2125.1998.00837.X

Identifiers

DOI

1 reference

10 August 2017

1 reference

10 August 2017

1 reference